University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Risperidone tablets

ESCA
Status: Amber Rivaroxaban tablets
  • Amber - specialist initation following diagnosis of AF- use in line with NICE. Initiation/ recommendation by a clinician who routinely initiates anticoagulants
  • Amber - specialist initation for the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/ recommendation by a clinician who routinely initiates anticoagulants. Where this is not the patient's GP, transfer to GP should be with the support of RICaD
  • Amber - specialist initiation for preventing adverse outcomes after acute management of ACS use in line with NICE TA335. Initiation/recommendation by a clinician who routinely initiates anticoagulants. Where this is not the patient's GP, transfer to GP should be with the support of RICaD
Status: Amber Rivastigmine capsules

Dementia drugs ESCA
Status: Amber Rivastigmine patches

Dementia drugs ESCA
Status: Amber Roflumilast (Daxas)

To be use in line with NICE. Supported with a RICaD
Status: Amber Ropinirole M/R tablets

ESCA for Parkinson's disease
Status: Amber Ropinirole tablets

ESCA for restless legs
Status: Amber Rosuvastatin tablets

40mg dose can be titrated up to on specialist recommendation for patient safety reasons as per the Summary Product Characteristics.
Status: Amber Rotigotine patches

Specialist initiation and stabilisation, ESCA
Status: Amber Rufinamide tablets

ESCA
Building healthier lives
Back to top